If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

Avian influenza timeline: From chickens to foxes, here's how bird flu is spreading across the US If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times ...

A new bird flu vaccine could be on the horizon after the U.S. has invested approximately $590 million to accelerate its development, the Department of Health and Human Services (HHS) announced on ...

Moderna also said on Wednesday that it had received positive interim data from a mid-stage trial set up to test the safety and immunogenicity of its bird flu vaccine targeting the H5 avian ...

Avian influenza timeline: From chickens to foxes, here's how bird flu is spreading across the US If successfully developed, Moderna’s mRNA-based pandemic flu vaccine could improve response times ...

Phase 1/2 H5 avian flu vaccine study shows positive interim results. Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines ...

Moderna has become the latest biopharma to benefit from the U.S. Department of Health and Human Services' concerns about avian flu, awarding the company $176 million to fund the clinical ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...

The worsening Avian Flu crisis adds optionality to Moderna shares. Moderna headquarters in Cambridge, MA, USA. JHVEPhoto/iStock Editorial via Getty Images.